| "Randomized, Embedded, Multifactorial Adaptive Platform trial for Community- Acquired Pneumonia (REMAP-CAP)" |
Ongoing |
Ceftriaxone - Piperacillin Tazobactam - Azithromycin - Interferon β1-a - Hydrocortisone sodium suc... - Hydroxychloroquine - OSELTAMIVIR - Lopinavir-Ritonavir |
3 |
CT20/001/R |
NGHA-R |
| Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Solifenacin succinate film-coated tablets (10 mg solifenacin succinate) versus Vesicare® film-coated tablets (10 mg solifenacin succinate), in healthy subjects under fasting condition. |
Ongoing |
solifenacin succinate |
1, BE |
42767 |
Saudi Ajal |
| Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. |
Ongoing |
Enoxa / Enoxaparin |
3, BE |
21-2017 |
Saudi Ajal |
| Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions. |
Ongoing |
Tacrolimus/ Prograf |
1, BE |
19-2017 |
Saudi Ajal |
| Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma |
Ongoing |
Sorafenib (Nexavar) |
3 |
RTOG 1112 |
KFSH & RC-R |
| "Randomized clinical trial of neoadjuvant chemotherapy with denosumab compared to chemotherapy alone in hormonal receptor-positive, HER2-negative premenopausal breast cancer patients" |
Ongoing |
DENOSUMAB |
3 |
20-610 |
King Abdullah Medical City (Makkah) |
| "randomised, multicentre, double-blind, placebo-controlled study of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)" |
Completed |
Ambrisentan 5 mg |
3 |
AMB115811 |
KFMC |
| RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity |
Ongoing |
Ranibizumab |
3 |
CRFB002H2301 V 01 |
KFSH & RC-R |
| "PROSPECTIVE, RANDOMIZED, OPEN LABEL CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE USE BEYOND 24 HOURS COMPARED WITH MIDAZOLAM IN CHILDREN ADMITTED TO PEDIATRIC INTENSIVE CARE UNIT (PICU) AT KASCH-MNGHA. (PROMISE)" |
Rejected |
Dexmedetomidine (Hospira) |
3 |
RC20/160/R |
King Abdulaziz Medical City NG (Riyadh) |
| Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KAMC-NGHA |
Rejected |
Dexmedetomidine (Precedex) |
3 |
RC11/084/R |
NGHA-R |
